Brochure | January 16, 2024

High-Quality eCOA Implemented Rapidly

GettyImages-1424259620 ecoa

The electronic clinical outcome assessment (eCOA) module within the Signant SmartSignals Unified Platform offers versatile usage options. It can operate independently or seamlessly integrate into Signant Biotech's comprehensive, unified platform, which includes electronic data capture (EDC/DDC), randomization and trial supply management (RTSM), eConsent, and TeleVisit.

This gives users the flexibility to opt for a self-service approach, allowing the customization of the solution using in-house teams. Alternatively, you can choose a full-service option, benefitting from the support of our dedicated and experienced project teams. These teams are backed by Signant Biotech's extensive operational, scientific, and regulatory expertise in eCOA, ensuring a well-rounded and proficient service delivery.

Explore the capabilities of this modern, eCOA solution for high-quality site- and home-based data collection by accessing the brochure below.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader